Rating History for Akero Therapeutics (AKRO) by BofA Securities
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/22/2024 | Alexandria Hammond | New Coverage | Neutral (N/A) |
30.00 (N/A) |
20.76 (20.79) |
0.14% | Details |
 |
|||||||
| Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|
| 4/22/2024 | Alexandria Hammond | New Coverage | Neutral (N/A) |
30.00 (N/A) |
20.76 (20.79) |
0.14% | Details |
|
|||||||
